CM Management »

Edesa Biotech shares owned by CM Management

Quarter-by-quarter ownership of Edesa Biotech (EDSA) shares owned by CM Management from 13F filings

Historical chart of CM Management investment in Edesa Biotech

Tip: Access up to 7 years of quarterly data

All positions including Edesa Biotech held by CM Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edesa Biotech by CM Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $283k 62k 4.57

More positions owned by CM Management

ImmunoGen
Amicus Therapeutics (FOLD)
Ali (ALCO)
Arko Corp (ARKO)
Radiant Logistics (RLGT)
Newmark Group Com - Class A (NMRK)
Bgc Group Inc Cl A (BGC)
Royalty Pharma (RPRX)
Taseko Cad (TGB)
Kyndryl Holdings Ord Wi (KD)
Pagerduty (PD)
National HealthCare Corporation (NHC)
Carrols Restaurant (TAST)
Coherus Biosciences (CHRS)
Ark Restaurants (ARKR)

View all positions for CM Management

Top funds holding Edesa Biotech

CM Management
Vanguard Group
Dimensional Fund Advisors
UBS Group
Royal Bank of Canada
TD Waterhouse Canada
Fifth Third Bancorp
Global Retirement Partners
Wells Fargo & Company
National Bank Of Canada /fi/
Global Wealth Strategies & Associates
Citigroup
AllSquare Wealth Management

View all funds holding Edesa Biotech